Skip to main content
. 2013 Nov 27;74(2):354–360. doi: 10.1136/annrheumdis-2013-204128

Figure 2.

Figure 2

Drug survival by TNF inhibitor initiation period. Hazard ratio adjusted for biologic drug, age, sex, period, education level, baseline HAQ, disease duration, concomitant DMARD, and general frailty.